• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
China Independent Clinical Laboratory Industry Report, 2013-2015 - Product Image

China Independent Clinical Laboratory Industry Report, 2013-2015

  • Published: September 2013
  • Region: China
  • 57 Pages
  • Research In China

FEATURED COMPANIES

  • Beijing Adinovo
  • Beijing NYMPHAVN
  • CapitalBio
  • Da An Gene
  • Deyi Diagnostics
  • DiAn Diagnostics
  • MORE

Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clinical laboratory market only values RMB2.5-3 billion, equivalent to 2%-3% of the total revenue of medical diagnosis, much lower than 30% in developed countries.

However, in the context of Chinese medical reform, the cost control of public hospitals, the increasing number of patients that primary medical institutions are confronted with, the rapid development of private hospitals and other factors will greatly boost China independent clinical laboratory industry which will grow at a rate over 40%.

The report focuses on the operation, advantages and characteristics of 10 major independent clinical laboratory companies in China on the basis of an analysis on the development environment, the market situation, the competition pattern, the impact of upstream and downstream as well as the prospect of China independent clinical laboratory industry.

In China, among about 110 laboratories engaged in independent medical diagnosis, top four ones, namely Kingmed Diagnostics, ADICON, READ MORE >

1 Overview of Independent Medical Diagnosis
1.1 Definition
1.2 Industry Chain

2 Overview of China Independent Clinical Laboratory Industry
2.1 Policy
2.1.1 Access Policy
2.1.2 Industrial Policy
2.2 Impact of International Market
2.2.1 Market Situation
2.2.2 Key Enterprises
2.3 Status Quo
2.4 Competition Pattern
2.5 Development Prospect and Trend

3 Upstream and Downstream of China Independent Clinical Laboratory Industry
3.1 Impact of Upstream Market
3.1.1 Market Situation
3.1.2 Competition Pattern
3.2 Impact of Downstream Development
3.2.1 Huge Independent Medical Diagnosis Market
3.2.2 Health Care Reform Propels the Rapid Development of the Independent Medical Diagnosis Market
3.2.3 Diversified Demand Will Promote the Upgrading of the Independent Clinical Laboratory Industry

4 Major Independent Clinical Laboratory Enterprises in China
4.1 Kingmed Diagnostics
4.1.1 Profile
4.1.2 Status Quo and Prospect
4.2 Hangzhou ADICON
4.3 DiAn Diagnostics
4.3.1 Profile
4.3.2 Operation
4.3.3 Business Structure
4.3.4 Gross Margin
4.3.5 Clients and Suppliers
4.3.6 R & D and Investment
4.3.7 Independent Medical Diagnostic Services
4.3.8 Development Prospect and Trend
4.4 Da An Gene
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 Clients and Suppliers
4.4.6 R & D
4.4.7 Independent Medical Diagnostic Services
4.5 Beijing NYMPHAVN
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 Clients
4.5.6 R & D and Investment
4.6 CapitalBio
4.7 Beijing Adinovo
4.8 Hangzhou Zhiyuan
4.9 Kindstar Global (Beijing)
4.10 Deyi Diagnostics

Selected Charts

Schematic Diagram of Independent Medical Diagnostic Industry Chain
Comparison between China and the U.S. in Medical Diagnosis Providers
Relevant Policies of China Independent Medical Diagnostic Industry, 2010-2012
Market Share of the U.S. Independent Medical Inspection Industry by Item
U.S. Medical Inspection Market Share (by Provider)
Revenue and Operating Profit of Quest Diagnostics, 2007-2013
Revenue Structure of Quest Diagnostics (by Business), 2011-2012
Major M & A Events of Quest Diagnostics, 2006-2013
Sales and Operating Profit of Labcorp, 2007-2013
Revenue of Labcorp (by Business), 2009-2013
Major M & A Events of Labcorp, 2007-2012
Comparison between Massachusetts General Hospital and One Chinese Grade-A Hospital in Top Five Outbound Inspection Items
Basic Characteristics and Market Share of Major Independent Clinical Laboratory Enterprises in China, by the end of 2012
Market Scale and Growth Rate of In Vitro Diagnostic Industry in China, 2007-2015E
Market Scale and Growth Rate of In Vitro Diagnostic Reagents in China, 2007-2015E
Structure of In Vitro Diagnostic Reagents in China, 2012
Chinese In Vitro Diagnostic Reagent Market Segments, 2012
Business and Inspection Revenue of Medical Institutions in China, 2010
Number of Patients of Hospitals and Primary Health Care Institutions in China, 2008-2012
Number of Public and Private Hospitals in China, 2008-2012
Revenue and YoY Growth Rate of Kingmed Diagnostics, 2008-2012
Distribution and Establishment Time of Independent Medical Laboratories of Hangzhou ADICON
Layout of Independent Diagnostic Laboratories of DiAn Diagnostics, by the end of 2012
Revenue and Profit of DiAn Diagnostics, 2008-2013
Revenue and Net Income of Top Five Subsidiaries of DiAn Diagnostics, 2011-2012
Revenue of DiAn Diagnostics (by Business), 2008-2013
Revenue Structure of DiAn Diagnostics (by Business), 2008-2013
Revenue of DiAn Diagnostics (by Region), 2008-2011
Revenue of DiAn Diagnostics (by Region), 2011-2013
Gross Margin of DiAn Diagnostics (by Business), 2008-2013
Revenue of DiAn Diagnostics from Top 5 Clients and % of Total Revenue, 2008-2013
Name List and Revenue Contribution of Top 5 Clients of DiAn Diagnostics, 2010-2013
Procurement of DiAn Diagnostics from Top 5 Suppliers and % of Total Procurement, 2008-2012
Name List and Procurement of Top 5 Suppliers of DiAn Diagnostics, 2009-2011
R&D Costs and % of Total Revenue of DiAn Diagnostics, 2008-2013
Revenue and Gross Margin of Independent Diagnostic Business of DiAn Diagnostic, 2008-2011
Revenue and Gross Margin of Independent Diagnostic Business of DiAn Diagnostic (by Product), 2008-2011
Revenue Percentage of Independent Diagnostic Business of DiAn Diagnostics (by Client), 2010-2012
Revenue and Operating Profit of DiAn Diagnostics (by Product), 2012-2015E
Revenue and Profit of Da An Gene, 2008-2013
Revenue of Da An Gene (by Product), 2008-2012
Revenue Structure of Da An Gene (by Region), 2008-2012
Gross Margin of Da An Gene (by Product), 2008-2012
Name List and Revenue Contribution of Top 5 Clients of Da An Gene, 2012
Name List and Procurement of Top 5 Suppliers of Da An Gene, 2012
R&D Costs and % of Total Revenue of Da An Gene, 2010-2012
Revenue and Gross Margin of Medical Laboratory Services of Da An Gene, 2008-2012
Registered Capital, Revenue and Net Income of Medical Laboratory Subsidiaries of Da An Gene, 2012
Revenue and Profit of NYMPHAVN, 2009-2013
Revenue of NYMPHAVN (by Product), 2009-2013
Revenue of NYMPHAVN (by Region), 2010-2012
Gross Margin of NYMPHAVN (by Product), 2009-2013
NYMPHAVN's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
Name List and Revenue Contribution of NYMPHAVN's Top 5 Clients, 2012-2013
R&D Costs and % of Total Revenue of NYMPHAVN, 2009-2012
Some Strategic Copartners of Adinovo
Major Events of Kindstar Global

- Beijing Adinovo
- Beijing NYMPHAVN
- CapitalBio
- Da An Gene
- Deyi Diagnostics
- DiAn Diagnostics
- Hangzhou ADICON
- Hangzhou Zhiyuan
- Kindstar Global (Beijing)
- Kingmed Diagnostics

Note: Product cover images may vary from those shown

ALSO AVAILABLE IN THE FOLLOWING LANGUAGES

RELATED PRODUCTS

Our Clients

Our clients' logos